Efficacy, Tolerability and Persistence of Subcutaneous Immunoglobulin Provided Through Immunology Physician Practices for the Treatment of Primary Immunodeficiencies

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.349
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Primary Immunodeficiencies

Mayo Clinic Proceedings
Medicine
1998English

Efficacy and Tolerability of Linezolid for Treatment of Infectious Spondylitis

The Korean Journal of Medicine
2018English

Tolerability of Higher Than Current Infusion Rate and Volume of the 20% Subcutaneous Immunoglobulin IgPro20 in Primary Immunodeficiency: An Open-Label Multicenter Study (HiLo)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Survey of Primary Care Physician Practices in Antibiotic Prescribing for the Treatment of Uncomplicated Male Gonoccocal Urethritis

BMC Family Practice
Family Practice
2011English

Clinical Comparison Between Patients With Selective Immunoglobulin a Deficiency and Other Primary Immunodeficiencies

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2015English

Immunoglobulin Replacement Treatment by Rapid Subcutaneous Infusion

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1998English

Primary Immunodeficiencies

2008English

The Tolerability and Efficacy of Levetiracetam

Canadian Journal of Neurological Sciences
MedicineNeurology
2010English

Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy